George Timothy Bowden
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
George Timothy Bowden has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
Raymond B. Nagle
Arizona Cancer Center, University of Arizona, Tucson, Arizona
8 shared publicationsZigang Dong
The Hormel Institute, University of Minnesota, Austin, Minnesota
4 shared publicationsAmy L. Silvers
Department of Radiation Oncology, Arizona Cancer Center, The University of Arizona, Tucson, AZ
3 shared publicationsErik R. Olson
Arizona Cancer Center, University of Arizona, Tucson, Arizona
3 shared publicationsJack Zhang
Department of Pharmacology, University of Arizona, Tucson, Arizona
3 shared publicationsT.S. Udayakumar
Department of Cell Biology and Anatomy, University of Arizona Health Sciences Center, Tucson, Arizona 85724, USA
3 shared publications
Latest Publications
- 25 January 2011
- Published by Wiley in Molecular Carcinogenesis
- Vol. 50 (6) , 469-478
p38 MAP kinase plays a functional role in UVB‐Induced mouse skin carcinogenesis
UVB irradiation of epidermal keratinocytes results in the activation of the p38 mitogen‐activated protein kinase (MAPK) pathway and subsequently activator protein‐1 (AP‐1) transcription factor activation and cyclooxygenase‐2 (COX‐2) expression. AP‐1 and COX‐2 have been shown to play functional roles in UVB‐induced mouse skin carcinogenesis. In this study, the experimental approach was to express a dominant negative p38α MAPK (p38DN) in the epidermis of SKH‐1 hairless mice and assess UVB‐induced AP‐1 activation, COX‐2 expression, and the skin carcinogenesis response in these mice compared to wild‐type littermates. We observed a significant inhibition of UVB‐induced AP‐1 activation and COX‐2 expression in p38DN transgenic mice, leading to a significant reduction of UVB‐induced tumor number and growth compared to wild‐type littermates in a chronic UVB skin carcinogenesis model. A potential mechanism for this reduction in tumor number and growth rate is an inhibition of chronic epidermal proliferation, observed as reduced Ki‐67 staining in p38DN mice compared to wild‐type. Although we detected no difference in chronic apoptotic rates between transgenic and nontransgenic mice, analysis of acutely irradiated mice demonstrated that expression of the p38DN transgene significantly inhibited UVB‐induced apoptosis of keratinocytes. These results counter the concerns that inhibition of p38 MAPK in a chronic situation could compromise the ability of the skin to eliminate potentially tumorigenic cells. Our data indicate that p38 MAPK is a good target for pharmacological intervention for UV‐induced skin cancer in patients with sun damaged skin, and suggest that inhibition of p38 signaling reduces skin carcinogenesis by inhibiting COX‐2 expression and proliferation of UVB‐irradiated cells.
- 25 January 2011
- Published by Wiley in Molecular Carcinogenesis
- Vol. 50 (6) , 469-478
p38 MAP kinase plays a functional role in UVB‐Induced mouse skin carcinogenesis
UVB irradiation of epidermal keratinocytes results in the activation of the p38 mitogen‐activated protein kinase (MAPK) pathway and subsequently activator protein‐1 (AP‐1) transcription factor activation and cyclooxygenase‐2 (COX‐2) expression. AP‐1 and COX‐2 have been shown to play functional roles in UVB‐induced mouse skin carcinogenesis. In this study, the experimental approach was to express a dominant negative p38α MAPK (p38DN) in the epidermis of SKH‐1 hairless mice and assess UVB‐induced AP‐1 activation, COX‐2 expression, and the skin carcinogenesis response in these mice compared to wild‐type littermates. We observed a significant inhibition of UVB‐induced AP‐1 activation and COX‐2 expression in p38DN transgenic mice, leading to a significant reduction of UVB‐induced tumor number and growth compared to wild‐type littermates in a chronic UVB skin carcinogenesis model. A potential mechanism for this reduction in tumor number and growth rate is an inhibition of chronic epidermal proliferation, observed as reduced Ki‐67 staining in p38DN mice compared to wild‐type. Although we detected no difference in chronic apoptotic rates between transgenic and nontransgenic mice, analysis of acutely irradiated mice demonstrated that expression of the p38DN transgene significantly inhibited UVB‐induced apoptosis of keratinocytes. These results counter the concerns that inhibition of p38 MAPK in a chronic situation could compromise the ability of the skin to eliminate potentially tumorigenic cells. Our data indicate that p38 MAPK is a good target for pharmacological intervention for UV‐induced skin cancer in patients with sun damaged skin, and suggest that inhibition of p38 signaling reduces skin carcinogenesis by inhibiting COX‐2 expression and proliferation of UVB‐irradiated cells.
- 27 October 2010
- Published by Springer Nature
- p. 335-363
Targeting UVB Mediated Signal Transduction Pathways for the Chemoprevention of Squamous Cell Carcinoma
- 27 October 2010
- Published by Springer Nature
- p. 335-363
Targeting UVB Mediated Signal Transduction Pathways for the Chemoprevention of Squamous Cell Carcinoma
- Open Access
- 31 August 2009
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 69 (17) , 7103-7110
Inhibition of Activator Protein-1 by Sulforaphane Involves Interaction with Cysteine in the cFos DNA-Binding Domain: Implications for Chemoprevention of UVB-Induced Skin Cancer
Sulforaphane is an isothiocyanate derived from cruciferous vegetables that has been linked to decreased risk of certain cancers. Although the role of sulforaphane in the induction of the transcription factor Nrf2 has been studied extensively, there is also evidence that inhibition of the transcription factor activator protein-1 (AP-1) may contribute to the chemopreventive properties of this compound. In this study, we show for the first time that sulforaphane is effective at reducing the multiplicity and tumor burden of UVB-induced squamous cell carcinoma in a mouse model using cotreatment with the compound and the carcinogen. We also show that sulforaphane pretreatment is able to reduce the activity of AP-1 luciferase in the skin of transgenic mice after UVB. Chromatin immunoprecipitation analysis verified that a main constituent of the AP-1 dimer, cFos, is inhibited from binding to the AP-1 DNA binding site by sulforaphane. Electrophoretic mobility shift assay analysis of nuclear proteins also shows that sulforaphane and diamide, both known to react with cysteine amino acids, are effective at inhibiting AP-1 from binding to its response element. Using truncated recombinant cFos and cJun, we show that mutation of critical cysteines in the DNA-binding domain of these proteins (Cys154 in cFos and Cys272 in cJun) results in loss of sensitivity to both sulforaphane and diamide in electrophoretic mobility shift assay analysis. Together, these data indicate that inhibition of AP-1 activity may be an important molecular mechanism in chemoprevention of squamous cell carcinoma by sulforaphane. [Cancer Res 2009;69(17):7103–10]
- 31 August 2009
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 69 (17) , 7103-7110
Open AccessInhibition of Activator Protein-1 by Sulforaphane Involves Interaction with Cysteine in the cFos DNA-Binding Domain: Implications for Chemoprevention of UVB-Induced Skin Cancer
Sulforaphane is an isothiocyanate derived from cruciferous vegetables that has been linked to decreased risk of certain cancers. Although the role of sulforaphane in the induction of the transcription factor Nrf2 has been studied extensively, there is also evidence that inhibition of the transcription factor activator protein-1 (AP-1) may contribute to the chemopreventive properties of this compound. In this study, we show for the first time that sulforaphane is effective at reducing the multiplicity and tumor burden of UVB-induced squamous cell carcinoma in a mouse model using cotreatment with the compound and the carcinogen. We also show that sulforaphane pretreatment is able to reduce the activity of AP-1 luciferase in the skin of transgenic mice after UVB. Chromatin immunoprecipitation analysis verified that a main constituent of the AP-1 dimer, cFos, is inhibited from binding to the AP-1 DNA binding site by sulforaphane. Electrophoretic mobility shift assay analysis of nuclear proteins also shows that sulforaphane and diamide, both known to react with cysteine amino acids, are effective at inhibiting AP-1 from binding to its response element. Using truncated recombinant cFos and cJun, we show that mutation of critical cysteines in the DNA-binding domain of these proteins (Cys154 in cFos and Cys272 in cJun) results in loss of sensitivity to both sulforaphane and diamide in electrophoretic mobility shift assay analysis. Together, these data indicate that inhibition of AP-1 activity may be an important molecular mechanism in chemoprevention of squamous cell carcinoma by sulforaphane. [Cancer Res 2009;69(17):7103–10]
- Open Access
- 1 October 2008
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 1 (5) , 362-368
Stabilization of Quercetin Paradoxically Reduces Its Proapoptotic Effect on UVB-Irradiated Human Keratinocytes
UVB light promotes survival of initiated keratinocytes, in part, by the direct activation of the phosphatidylinositol 3-kinase (PI3K) signaling pathway. Novel chemopreventative agents targeting UVB-induced signaling pathways are needed to reduce the incidence of nonmelanoma skin cancer. Quercetin (Qu) is a dietary flavonoid and a known inhibitor of PI3K. We determined that Qu degrades rapidly when diluted in DMEM and incubated under normal cell culture conditions. Degradation was delayed by supplementing the medium with 1 mmol/L ascorbic acid (AA), and as expected, stabilization actually increased the effectiveness of Qu as a PI3K inhibitor because basal and UVB-induced Akt phosphorylation were reduced compared with Qu treatment in the absence of AA. Although AA stabilization increased Qu-induced apoptosis in mock-irradiated HaCaT cells, consistent with it acting as a PI3K inhibitor (13.4% Annexin V–positive cells for AA-stabilized Qu versus 6.3% for Qu), AA stabilization of Qu actually reduced the ability of the compound to induce apoptosis of UVB-irradiated HaCaTs (29.7% of Qu-treated cells versus 15.5% of AA + Qu–treated cells). Similar trends were seen in the analysis of caspase-3 and poly(ADP-ribose) polymerase cleavage. Qu is known to oxidize to form reactive products, and we found that dihydroethidium is oxidized by Qu regardless of whether or not it was stabilized. Although redox cycling occurs even in the presence of AA, stabilization reduces the accumulation of reactive Qu products that contribute to the proapoptotic effect of the compound, and thus reduces the ability of the compound to induce apoptosis of UVB-irradiated HaCaT cells.
- 1 October 2008
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 1 (5) , 362-368
Open AccessStabilization of Quercetin Paradoxically Reduces Its Proapoptotic Effect on UVB-Irradiated Human Keratinocytes
UVB light promotes survival of initiated keratinocytes, in part, by the direct activation of the phosphatidylinositol 3-kinase (PI3K) signaling pathway. Novel chemopreventative agents targeting UVB-induced signaling pathways are needed to reduce the incidence of nonmelanoma skin cancer. Quercetin (Qu) is a dietary flavonoid and a known inhibitor of PI3K. We determined that Qu degrades rapidly when diluted in DMEM and incubated under normal cell culture conditions. Degradation was delayed by supplementing the medium with 1 mmol/L ascorbic acid (AA), and as expected, stabilization actually increased the effectiveness of Qu as a PI3K inhibitor because basal and UVB-induced Akt phosphorylation were reduced compared with Qu treatment in the absence of AA. Although AA stabilization increased Qu-induced apoptosis in mock-irradiated HaCaT cells, consistent with it acting as a PI3K inhibitor (13.4% Annexin V–positive cells for AA-stabilized Qu versus 6.3% for Qu), AA stabilization of Qu actually reduced the ability of the compound to induce apoptosis of UVB-irradiated HaCaTs (29.7% of Qu-treated cells versus 15.5% of AA + Qu–treated cells). Similar trends were seen in the analysis of caspase-3 and poly(ADP-ribose) polymerase cleavage. Qu is known to oxidize to form reactive products, and we found that dihydroethidium is oxidized by Qu regardless of whether or not it was stabilized. Although redox cycling occurs even in the presence of AA, stabilization reduces the accumulation of reactive Qu products that contribute to the proapoptotic effect of the compound, and thus reduces the ability of the compound to induce apoptosis of UVB-irradiated HaCaT cells.
- 22 February 2008
- Published by Wiley in The Prostate
- Vol. 68 (5) , 463-476
Differential localization of MT1‐MMP in human prostate cancer tissue: Role of IGF‐1R in MT1‐MMP expression
Background: MT1‐MMP is a metalloproteinase involved in prostate cancer metastasis. The IGF‐1R is a tyrosine kinase receptor involved with tumor progression and metastasis. The purpose of this investigation was to examine MT1‐MMP and IGF‐1R expression and localization in prostate cancer tissues and explore the role of IGF‐1R in regulating MT1‐MMP in prostate cancer cell lines.Methods: Immunohistochemistry was utilized to study MT1‐MMP and IGF‐1R expression in human prostate tissues. IGF‐1R regulation of MT1‐MMP expression was determined by gene promoter analysis, quantitative RT‐PCR and Western blot analysis following pharmacological inhibition of the receptor in PC‐3N cells and treatment of LNCaP cells with androgen and IGF‐1.Results: MT1‐MMP expression was high in the apical regions of the luminal cells in PIN and prostate cancer and less intense in the basalateral regions of benign tissues. IGF‐1R was expressed primarily in the basal cells of normal glands and highly expressed in prostate cancer. Inhibition of IGF‐1R in PC‐3N cells decreased MT1‐MMP expression and treatment of LNCaP cells with a synthetic androgen and IGF‐1 increased MT1‐MMP expression.Conclusions: These data demonstrate that MT1‐MMP is highly expressed in the apical cytoplasmic regions of the luminal cells in PIN and prostate cancer when compared to basalateral cytoplasmic membrane staining in benign glands. Additionally, we demonstrate that IGF‐1R is highly expressed in human prostate carcinoma. These findings suggest that MT1‐MMP localization and IGF‐1R expression in prostate carcinoma could be predictive biomarkers for aggressive disease and support IGF‐1R as a promising therapeutic target to decrease processes of prostate cancer metastasis. Prostate 68: 463–476, 2008.
- 22 February 2008
- Published by Wiley in The Prostate
- Vol. 68 (5) , 463-476
Differential localization of MT1‐MMP in human prostate cancer tissue: Role of IGF‐1R in MT1‐MMP expression
Background: MT1‐MMP is a metalloproteinase involved in prostate cancer metastasis. The IGF‐1R is a tyrosine kinase receptor involved with tumor progression and metastasis. The purpose of this investigation was to examine MT1‐MMP and IGF‐1R expression and localization in prostate cancer tissues and explore the role of IGF‐1R in regulating MT1‐MMP in prostate cancer cell lines.Methods: Immunohistochemistry was utilized to study MT1‐MMP and IGF‐1R expression in human prostate tissues. IGF‐1R regulation of MT1‐MMP expression was determined by gene promoter analysis, quantitative RT‐PCR and Western blot analysis following pharmacological inhibition of the receptor in PC‐3N cells and treatment of LNCaP cells with androgen and IGF‐1.Results: MT1‐MMP expression was high in the apical regions of the luminal cells in PIN and prostate cancer and less intense in the basalateral regions of benign tissues. IGF‐1R was expressed primarily in the basal cells of normal glands and highly expressed in prostate cancer. Inhibition of IGF‐1R in PC‐3N cells decreased MT1‐MMP expression and treatment of LNCaP cells with a synthetic androgen and IGF‐1 increased MT1‐MMP expression.Conclusions: These data demonstrate that MT1‐MMP is highly expressed in the apical cytoplasmic regions of the luminal cells in PIN and prostate cancer when compared to basalateral cytoplasmic membrane staining in benign glands. Additionally, we demonstrate that IGF‐1R is highly expressed in human prostate carcinoma. These findings suggest that MT1‐MMP localization and IGF‐1R expression in prostate carcinoma could be predictive biomarkers for aggressive disease and support IGF‐1R as a promising therapeutic target to decrease processes of prostate cancer metastasis. Prostate 68: 463–476, 2008.
- Open Access
- 15 February 2008
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (4) , 1046-1054
Nucleolin StabilizesBcl-XLMessenger RNA in Response to UVA Irradiation
Our laboratory has previously reported that UVA irradiation can increase the expression of Bcl-XL, an antiapoptotic molecule, by stabilizing its mRNA in cultured immortalized human keratinocytes. To understand the mechanism by which the Bcl-XL message is stabilized, we used a synthetic Bcl-XL 3′-untranslated region (UTR) to capture RNA-binding proteins. Nucleolin was identified as one of the binding proteins as determined by tandem mass spectrometry coupled to liquid chromatography analysis. Further study showed that nucleolin specifically recognized the AU-rich elements (AUUUA) in the 3′-UTR of the Bcl-XL mRNA and could stabilize the mRNA in vitro. Furthermore, overexpression of nucleolin stabilizes the Bcl-XL mRNA in HeLa cells, whereas reducing nucleolin by small interfering RNA shortens the Bcl-XL mRNA half-life. Interestingly, nucleolin physically interacted with polyadenylate [poly(A)]–binding protein through it RGG motifs. Its stabilizing effect on the Bcl-XL mRNA was dependent upon the presence of poly(A) tail. Based on these data, we propose a model in which nucleolin protects the Bcl-XL mRNA from nuclease degradation by enhancing the stability of the ribonucleoprotein loop structure. [Cancer Res 2008;68(4):1046–54]
- 15 February 2008
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (4) , 1046-1054
Open AccessNucleolin StabilizesBcl-XLMessenger RNA in Response to UVA Irradiation
Our laboratory has previously reported that UVA irradiation can increase the expression of Bcl-XL, an antiapoptotic molecule, by stabilizing its mRNA in cultured immortalized human keratinocytes. To understand the mechanism by which the Bcl-XL message is stabilized, we used a synthetic Bcl-XL 3′-untranslated region (UTR) to capture RNA-binding proteins. Nucleolin was identified as one of the binding proteins as determined by tandem mass spectrometry coupled to liquid chromatography analysis. Further study showed that nucleolin specifically recognized the AU-rich elements (AUUUA) in the 3′-UTR of the Bcl-XL mRNA and could stabilize the mRNA in vitro. Furthermore, overexpression of nucleolin stabilizes the Bcl-XL mRNA in HeLa cells, whereas reducing nucleolin by small interfering RNA shortens the Bcl-XL mRNA half-life. Interestingly, nucleolin physically interacted with polyadenylate [poly(A)]–binding protein through it RGG motifs. Its stabilizing effect on the Bcl-XL mRNA was dependent upon the presence of poly(A) tail. Based on these data, we propose a model in which nucleolin protects the Bcl-XL mRNA from nuclease degradation by enhancing the stability of the ribonucleoprotein loop structure. [Cancer Res 2008;68(4):1046–54]
- 1 August 2007
- Published by Wiley in Molecular Carcinogenesis
- Vol. 46 (8) , 665-670
Targeting Bcl-XL for prevention and therapy of skin cancer
Apoptosis plays an important role in skin carcinogenesis. Bcl‐XL, an antiapoptotic Bcl‐2 family member, is a key regulator in the process. Aberrant expression of Bcl‐XL allows cells carrying mutations to survive and propagate. Overexpression of Bcl‐XL is correlated with tumor malignancy and invasion. Importantly, deregulation of Bcl‐XL confers drug resistance to chemotherapy. Therefore, targeting Bcl‐XL in combination with conventional chemotherapy is a promising way to pursue cancer chemotherapy. Several compounds targeting Bcl‐XL expression or function have shown their potential in chemoprevention and of chemotherapy of cancer.
- 1 August 2007
- Published by Wiley in Molecular Carcinogenesis
- Vol. 46 (8) , 665-670
Targeting Bcl-XL for prevention and therapy of skin cancer
Apoptosis plays an important role in skin carcinogenesis. Bcl‐XL, an antiapoptotic Bcl‐2 family member, is a key regulator in the process. Aberrant expression of Bcl‐XL allows cells carrying mutations to survive and propagate. Overexpression of Bcl‐XL is correlated with tumor malignancy and invasion. Importantly, deregulation of Bcl‐XL confers drug resistance to chemotherapy. Therefore, targeting Bcl‐XL in combination with conventional chemotherapy is a promising way to pursue cancer chemotherapy. Several compounds targeting Bcl‐XL expression or function have shown their potential in chemoprevention and of chemotherapy of cancer.
- 1 June 2007
- Published by Bentham Science Publishers Ltd. in Current Cancer Drug Targets
- Vol. 7 (4) , 325-334
Ultraviolet B Regulation of Transcription Factor Families: Roles of Nuclear Factor-kappa B (NF-κB) and Activator Protein-1 (AP-1) in UVB-Induced Skin Carcinogenesis
Prolonged and repeated exposure of the skin to ultraviolet light (UV) leads not only to aging of the skin but also increases the incidence of non-melanoma skin cancer (NMSC). Damage of cells induced by ultraviolet B (UVB) light both at the DNA level and molecular level initiates the activation of transcription factor pathways, which in turn regulate the expression of a number of genes termed the “UV response genes”. Two such transcription factor families that are activated in this way are those of the nuclear factor-κB (NF-κB) and activator protein-1 (AP-1) families. These two transcription factor families have been identified to be involved in the processes of cell proliferation, cell differentiation and cell survival and therefore play important roles in tumorigenesis. The study of these two transcription factor pathways and the cross-talk between them in response to UVB exposure may help with the development of new chemopreventive strategies for the prevention of UVB-induced skin carcinogenesis.
- 1 June 2007
- Published by Bentham Science Publishers Ltd. in Current Cancer Drug Targets
- Vol. 7 (4) , 325-334
Ultraviolet B Regulation of Transcription Factor Families: Roles of Nuclear Factor-kappa B (NF-κB) and Activator Protein-1 (AP-1) in UVB-Induced Skin Carcinogenesis
Prolonged and repeated exposure of the skin to ultraviolet light (UV) leads not only to aging of the skin but also increases the incidence of non-melanoma skin cancer (NMSC). Damage of cells induced by ultraviolet B (UVB) light both at the DNA level and molecular level initiates the activation of transcription factor pathways, which in turn regulate the expression of a number of genes termed the “UV response genes”. Two such transcription factor families that are activated in this way are those of the nuclear factor-κB (NF-κB) and activator protein-1 (AP-1) families. These two transcription factor families have been identified to be involved in the processes of cell proliferation, cell differentiation and cell survival and therefore play important roles in tumorigenesis. The study of these two transcription factor pathways and the cross-talk between them in response to UVB exposure may help with the development of new chemopreventive strategies for the prevention of UVB-induced skin carcinogenesis.